IRIS
SAVARINO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 52.184
AS - Asia 4.464
NA - Nord America 1.824
SA - Sud America 364
AF - Africa 78
OC - Oceania 5
Totale 58.919
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 51.406
SG - Singapore 2.040
US - Stati Uniti d'America 1.703
CN - Cina 1.191
VN - Vietnam 713
FR - Francia 411
BR - Brasile 232
HK - Hong Kong 166
FI - Finlandia 81
DE - Germania 80
AR - Argentina 63
MX - Messico 62
IN - India 58
GB - Regno Unito 54
JP - Giappone 53
CA - Canada 43
IQ - Iraq 40
BD - Bangladesh 37
NL - Olanda 30
CH - Svizzera 26
EC - Ecuador 22
ID - Indonesia 21
TR - Turchia 15
RU - Federazione Russa 14
ES - Italia 13
IE - Irlanda 13
TH - Thailandia 13
ZA - Sudafrica 13
NP - Nepal 12
PH - Filippine 12
VE - Venezuela 12
CL - Cile 11
JO - Giordania 11
MA - Marocco 11
SA - Arabia Saudita 11
KE - Kenya 10
PE - Perù 9
PL - Polonia 9
TW - Taiwan 8
CO - Colombia 7
KR - Corea 7
LT - Lituania 7
UA - Ucraina 7
DZ - Algeria 6
OM - Oman 6
PK - Pakistan 6
TN - Tunisia 6
BH - Bahrain 5
SI - Slovenia 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
BY - Bielorussia 4
MY - Malesia 4
PY - Paraguay 4
SN - Senegal 4
AT - Austria 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
IR - Iran 3
SE - Svezia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BE - Belgio 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MN - Mongolia 2
NG - Nigeria 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
TG - Togo 2
UY - Uruguay 2
YT - Mayotte 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
LC - Santa Lucia 1
LS - Lesotho 1
Totale 58.900
Salva come PNG Salva come JPEG
Città #
Genova 33.728
Genoa 10.462
Rapallo 4.096
Vado Ligure 2.886
Singapore 920
San Jose 751
Lauterbourg 400
Ho Chi Minh City 219
Ashburn 176
Hong Kong 166
Hanoi 158
New York 148
Beijing 143
Council Bluffs 83
Helsinki 77
Frankfurt am Main 65
Santa Clara 64
Bordighera 62
Orem 54
Tokyo 46
Mexico City 39
Da Nang 32
Los Angeles 29
Tianjin 26
Amsterdam 25
Haiphong 25
Zurich 25
St Louis 20
São Paulo 20
Rome 19
Milan 18
Chennai 17
Hải Dương 16
Guangzhou 15
Bologna 14
Montreal 14
Baghdad 13
Dublin 12
Poplar 12
Amman 11
Atlanta 11
Chicago 11
Mumbai 11
City of London 10
Dallas 10
Shanghai 10
Biên Hòa 9
Nairobi 9
Rio de Janeiro 9
Toronto 9
Warsaw 9
Buffalo 8
Can Tho 8
Cardiff 8
Curitiba 8
Ninh Bình 8
Quito 8
Quảng Ngãi 8
Bangkok 7
Des Moines 7
Fortaleza 7
London 7
Guayaquil 6
Lima 6
Manchester 6
Querétaro 6
Buenos Aires 5
Bắc Ninh 5
Chengdu 5
Dhaka 5
Erbil 5
Ljubljana 5
Madrid 5
Modena 5
Muscat 5
Naples 5
Quận Ba 5
Riyadh 5
Tashkent 5
Thái Bình 5
Ankara 4
Bari 4
Cape Town 4
Dakar 4
Guarulhos 4
Houston 4
Minsk 4
Moscow 4
New Delhi 4
Orangeburg 4
Phoenix 4
Phủ Lý 4
Porto Alegre 4
Shenzhen 4
Thái Nguyên 4
Vĩnh Long 4
Basra 3
Bauru 3
Boston 3
Brasília 3
Totale 55.468
Salva come PNG Salva come JPEG
Nome #
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 238
Proton pump inhibitors: use and misuse in the clinical setting 235
5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for “best evidence”? 216
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 214
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 208
Positive PET in a patient with esophageal leiomyoma. 208
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 206
Time pattern of gastric acidity in Barrett's esophagus 203
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index 202
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 199
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 198
13C-mixed triglyceride (13C-MTG) breath-test (BT) in Cystic Fibrosis (CF). 197
Circadian monitoring of gastric juice mutagenicity. 197
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 196
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 196
Are proton pump inhibitors really so dangerous? 195
A safety review of proton pump inhibitors to treat acid-related digestive diseases 195
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 193
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 193
Barrett's esophagus in 2016: From pathophysiology to treatment 192
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 190
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 190
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. 190
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up 189
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 189
24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. 188
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 188
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 187
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 187
A study of 4-and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication 187
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 186
Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study 186
Measurement of oro-caecal transit time by magnetic resonance imaging. 184
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 183
Ilaprazole for the treatment of gastro-esophageal reflux 182
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease 182
Breath tests to assess alcoholic liver disease. 181
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 180
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis 179
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 179
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 179
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 178
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. 178
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. 176
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy 176
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn 176
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 174
24-H comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. 174
A comparison of five maintenance therapies for reflux esophagitis 173
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. 173
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 173
Circadian reduction of chromium in the gastric environment. 173
Can artificial neural networks be beneficial in diagnosing gastro-oesophageal reflux disease? 173
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 171
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease 171
Burden of illness in Italian patients with gastro-oesophageal reflux disease. 170
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 170
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. 170
Acid and gastric metaplasia in the duodenum 169
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 169
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 167
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 167
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 167
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 167
Starry Liver: An Unexpected Diagnosis 166
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease. 166
The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up 166
A Nodule, is a Nodule, is a Nodule: May Alpha-fetoprotein Make the Difference? 166
Anti-TNF Antibodies For Prevention of Crohn's Disease Recurrence After Surgery: More Than An Hope. 166
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 166
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 166
Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma 165
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 165
Adalimumab trough levels and response to biological treatment in patients with Inflammatory Bowel Disease: a useful cut-off In clinical practice. 164
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 163
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases 163
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals 161
An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic hepatitis C virus infection and advanced liver disease 159
Comparison between laparoscopy, ultrasonography, and computed tomography in widespread and localized liver diseases. 159
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 158
Assessment of Intestinal Permeability Using Sugar Probes: Influence of Urinary Volume 158
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 158
13C-octanoic ac. Breath test: neural network analysis of 13C excretion data 157
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients. 156
External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis 156
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 156
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab. 156
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 156
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens 155
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 155
Letter: Biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease 155
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 155
Blessed are those who have not seen and yet have believed 154
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease 154
Anti-helicobacter regimens 153
Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs pantoprazole. 153
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 153
Discriminant value of dyspepsia subgroups. 153
OAM for cure of Helicobacter pylori infection. 153
NERD: an umbrella term including heterogeneous subpopulations. 153
Totale 17.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 176.372
article - articoli 164.250
book - libri 494
conference - conferenze 2.585
curatela - curatele 0
other - altro 8.752
patent - brevetti 0
selected - selezionate 0
volume - volumi 291
Totale 352.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021835 0 0 0 0 0 0 0 0 0 354 224 257
2021/20225.241 161 297 378 744 235 408 388 1.125 212 497 177 619
2022/20234.913 530 265 60 424 947 890 6 379 886 32 437 57
2023/20242.217 117 319 50 224 185 396 129 100 138 39 142 378
2024/20257.016 275 599 263 452 959 718 570 1.066 279 293 695 847
2025/202611.144 1.420 298 927 1.117 1.408 1.476 2.042 553 810 1.093 0 0
Totale 59.545